(+)-VINCRISTINE
Anaplastic Large Cell Lymphoma
Seagen Inc.Small moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 66/ 100
- Competitive Position
- 81/ 100
Competitive context
34 Active assets in the Anaplastic Large Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 Children's Cancer Group, China | Phase 4 | BBB |
Cyclophosphamide National Cancer Institute (NCI) | Phase 4 | BBB |
Ifosfamide National Cancer Institute (NCI) | Phase 4 | BB |
ETOPOSIDE City of Hope Medical Center | Phase 4 | BB |
METHOTREXATE Children's Cancer Group, China | Phase 4 | BB |
View all 50 →
Same molecule, other indications
(+)-VINCRISTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →